Ruilei Liu1,2, Ruiming Liu3, Jie Li1, Yu Liu2, Hua Jiang2, Shenming Wang1. 1. Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Sun Yat-sen University Guangzhou 510000, P.R. China. 2. Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-sen University Guangzhou 510000, P.R. China. 3. Laboratory of Department of Surgery, The First Affiliated Hospital of Sun Yat-sen University P.R. China.
Abstract
OBJECTIVE: In recent years, Mena (Mammalian Enabled) has been reported to be highly expressed in malignant tumors. However, data on the expression pattern and clinical relevance of Mena in thyroid carcinoma are unclear. The purpose of this study was to investigate the expression of Mena and its prognostic significance in human thyroid carcinoma. MATERIALS AND METHODS: Mena expression at the mRNA level was examined by real-time quantitative polymerase chain reaction (RT-PCR) in 8 paired thyroid carcinoma and adjacent normal tissues. Mena protein expression in clinical samples was analyzed in paraffin-embedded papillary thyroid carcinoma samples and normal thyroid tissues by immunohistochemistry (IHC). Statistical analyses were also performed to evaluate the clinicopathological significance of Mena expression. RESULTS: The results show that expression of Mena mRNA is higher in thyroid carcinoma than in adjacent normal tissues in 8 paired samples. In paraffin-embedded tissue samples, the expression of Mena was higher in papillary thyroid carcinoma than normal thyroid tissues. Compared with normal thyroid tissues, overexpression of Mena was detected in 47.11% (57/121) of papillary thyroid carcinoma patients. Overexpression of Mena was significantly associated with T Stage (P = 0.007), capsular invasion (P = 0.015), lymph node metastasis (P = 0.000), and clinical stage (P = 0.029). CONCLUSION: Mena is up-regulated in thyroid carcinoma and is associated with expression of T Stage, lymph node metastasis, clinical stage and disease-free survival. Mena may serve as a prognostic indicator for patients with thyroid carcinoma. IJCEP
OBJECTIVE: In recent years, Mena (Mammalian Enabled) has been reported to be highly expressed in malignant tumors. However, data on the expression pattern and clinical relevance of Mena in thyroid carcinoma are unclear. The purpose of this study was to investigate the expression of Mena and its prognostic significance in humanthyroid carcinoma. MATERIALS AND METHODS:Mena expression at the mRNA level was examined by real-time quantitative polymerase chain reaction (RT-PCR) in 8 paired thyroid carcinoma and adjacent normal tissues. Mena protein expression in clinical samples was analyzed in paraffin-embedded papillary thyroid carcinoma samples and normal thyroid tissues by immunohistochemistry (IHC). Statistical analyses were also performed to evaluate the clinicopathological significance of Mena expression. RESULTS: The results show that expression of Mena mRNA is higher in thyroid carcinoma than in adjacent normal tissues in 8 paired samples. In paraffin-embedded tissue samples, the expression of Mena was higher in papillary thyroid carcinoma than normal thyroid tissues. Compared with normal thyroid tissues, overexpression of Mena was detected in 47.11% (57/121) of papillary thyroid carcinomapatients. Overexpression of Mena was significantly associated with T Stage (P = 0.007), capsular invasion (P = 0.015), lymph node metastasis (P = 0.000), and clinical stage (P = 0.029). CONCLUSION:Mena is up-regulated in thyroid carcinoma and is associated with expression of T Stage, lymph node metastasis, clinical stage and disease-free survival. Mena may serve as a prognostic indicator for patients with thyroid carcinoma. IJCEP
Authors: Karin Kühnel; Thomas Jarchau; Eva Wolf; Ilme Schlichting; Ulrich Walter; Alfred Wittinghofer; Sergei V Strelkov Journal: Proc Natl Acad Sci U S A Date: 2004-11-29 Impact factor: 11.205
Authors: Weigang Wang; Jeffrey B Wyckoff; Sumanta Goswami; Yarong Wang; Mazen Sidani; Jeffrey E Segall; John S Condeelis Journal: Cancer Res Date: 2007-04-15 Impact factor: 12.701
Authors: Ulrike Philippar; Evanthia T Roussos; Matthew Oser; Hideki Yamaguchi; Hyung-Do Kim; Silvia Giampieri; Yarong Wang; Sumanta Goswami; Jeffrey B Wyckoff; Douglas A Lauffenburger; Erik Sahai; John S Condeelis; Frank B Gertler Journal: Dev Cell Date: 2008-12 Impact factor: 12.270
Authors: Xing Judy Chen; Anna Julia Squarr; Raiko Stephan; Baoyu Chen; Theresa E Higgins; David J Barry; Morag C Martin; Michael K Rosen; Sven Bogdan; Michael Way Journal: Dev Cell Date: 2014-09-08 Impact factor: 12.270